MPM
GSK icon

Meritage Portfolio Management’s GSK GSK Stock Holding History

Meritage Portfolio Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-157,102
Closed -$5.31M – 333
2024
Q4 		$5.31M Sell
157,102
-2,544
-2% -$91.6K 0.33% 79
2024
Q3 		$6.53M Sell
159,646
-3,655
-2% -$150K 0.4% 70
2024
Q2 		$6.29M Sell
163,301
-2,209
-1% -$92.9K 0.4% 70
2024
Q1 		$7.09M Sell
165,510
-11,512
-7% -$475K 0.45% 61
2023
Q4 		$6.56M Sell
177,022
-1,708
-1% -$61.3K 0.43% 63
2023
Q3 		$6.48M Sell
178,730
-4,298
-2% -$153K 0.48% 60
2023
Q2 		$6.52M Sell
183,028
-11,238
-6% -$403K 0.46% 63
2023
Q1 		$6.91M Buy
194,266
+139
+0.1% +$4.86K 0.52% 60
2022
Q4 		$6.82M Buy
194,127
+104,907
+118% +$3.49M 0.53% 57
2022
Q3 		$2.63M Sell
89,220
-9,044
-9% -$343K 0.22% 134
2022
Q2 		$5.35M Buy
98,264
+1,368
+1% +$75.5K 0.41% 79
2022
Q1 		$5.28M Buy
+96,896
New +$5.26M 0.33% 94
2016
Q2 		– Sell
-99,651
Closed -$5.05M – 197
2016
Q1 		$5.05M Buy
99,651
+8,372
+9% +$417K 0.57% 76
2015
Q4 		$4.6M Sell
91,279
-2,706
-3% -$138K 0.52% 90
2015
Q3 		$4.52M Sell
93,985
-22,969
-20% -$1.2M 0.52% 86
2015
Q2 		$6.09M Sell
116,954
-748
-0.6% -$42.1K 0.64% 48
2015
Q1 		$6.79M Buy
117,702
+12,372
+12% +$709K 0.68% 34
2014
Q4 		$5.63M Sell
105,330
-819
-0.8% -$45.8K 0.6% 59
2014
Q3 		$6.1M Buy
106,149
+26,892
+34% +$1.65M 0.69% 34
2014
Q2 		$5.3M Buy
79,257
+21,524
+37% +$1.46M 0.58% 64
2014
Q1 		$3.86M Buy
57,733
+1,504
+3% +$102K 0.46% 123
2013
Q4 		$3.75M Sell
56,229
-693
-1% -$44.9K 0.46% 115
2013
Q3 		$3.57M Buy
56,922
+1,932
+4% +$124K 0.46% 112
2013
Q2 		$3.44M Buy
+54,990
New +$3.49M 0.49% 104

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Meritage Portfolio Management's GSK Position: Q1 2025 in Review

Meritage Portfolio Management sold out of GSK (GSK) in Q1 2025, closing a stake of 157,102 shares — an estimated $5.31M sold.

Meritage Portfolio Management first reported a position in GSK in Q2 2013 and held it in 24 quarters. The position peaked at $7.09M in Q1 2024. 857 funds tracked by Wall St. Rank hold GSK as of Q1 2025.

  • Meritage Portfolio Management reported no remaining GSK position as of Q1 2025 after selling out during the quarter.
  • Meritage Portfolio Management sold 157,102 GSK shares in Q1 2025, an estimated $5.31M.
  • Meritage Portfolio Management first reported a position in GSK in Q2 2013 and held it in 24 quarters.
  • Meritage Portfolio Management's GSK position peaked at $7.09M in Q1 2024.
  • 857 funds tracked by Wall St. Rank held GSK as of Q1 2025.

Based on Meritage Portfolio Management's 13F filing for Q1 2025, filed 28 Apr 2025.